Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine
   Position   Associate Professor
Article types Original article
Language English
Peer review Peer reviewed
Title Impact of continued administration of tolvaptan on cirrhotic patients with ascites.
Journal Formal name:BMC pharmacology & toxicology
Abbreviation:BMC Pharmacol Toxicol
ISSN code:(2050-6511)2050-6511(Linking)
Domestic / ForeginForegin
Volume, Issue, Page 19(1),pp.87
Author and coauthor KOGISO Tomomi,SAGAWA Takaomi,KODAMA Kazuhisa,TANIAI Makiko,TOKUSHIGE Katsutoshi
Publication date 2018/12
Summary Long-term tolvaptan treatment increased serum levels of albumin, decreased ammonia levels, and preserved renal function after 1 year of treatment. A reduction in body weight after 1 week was associated with a favorable outcome of tolvaptan therapy.
DOI 10.1186/s40360-018-0277-3
PMID 30563565